Pure Global AI
ANVISA registration 81541770003Valid until Jul 21, 2035

GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING

ANVISA Registration Number: 81541770003SUPER DIAGNOSTICA PRODS HOSP LTDA EPPLABSYSTEMS DIAGNOSTICS OYRisk Class III
Device names
Technical name
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING
PT: DESIDROGENASE GLICOSE-6-FOSFATO (G6PD) - TRIAGEM NEONATAL
Commercial name
Neonatal G6PD
Risk class
Class III
Registration details
Registration Number
81541770003
Process Number
25351022642202577
CNPJ
27437056000164
Company information
Manufacturing Country
Finland
PT: FINLÂNDIA
Dates and status
Publication Date
Jul 21, 2025
Validity
21/07/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81541770003 and manufactured by LABSYSTEMS DIAGNOSTICS OY. The registration is held by SUPER DIAGNOSTICA PRODS HOSP LTDA EPP with validity until Jul 21, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.